ENTITY
Oneness Biotech

Oneness Biotech (4743 TT)

20
Analysis
Health CareTaiwan
Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.
more
bullishOneness Biotech
23 Jul 2024 09:30

Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream

​Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...

Logo
318 Views
Share
bullishOneness Biotech
14 May 2023 23:49

Oneness Biotech (4743 TT): Global Expansion of Marketed Product & Pipeline Progress

Fespixon got approvals for Taiwan and Singapore markets. Bonvadis as a medical device for wound management has been granted market approvals in US,...

Logo
304 Views
Share
bullishOneness Biotech
30 Aug 2022 16:23

Oneness Biotech (4743 TT): Positive Clinical Trial Progress Is Pushing Stock Prices to Higher Highs

Oneness submitted an IND application to the FDA for a phase 1 clinical trial of SNS812 for the treatment of the COVID-19 infection. Fespixon is...

Logo
183 Views
Share
bullishOneness Biotech
19 Mar 2022 18:15

Oneness Biotech (4743 TT): Worth of Attention Ahead of Upcoming Key Milestones

The company’s flagship drug Fespixon has $14 billion global market opportunity, while other late-stage pipeline entail visibility in the long-term....

Logo
368 Views
Share
x